4basebio PLC · LSE:4BB

Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))'s stake in 4basebio PLC fell to 27.80% (TR-1 holding notification)

Event Nov 10, 2026 · Filed Nov 12, 2026

Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))'s stake in 4basebio PLC fell to 27.80%, 5,350,075 shares on Nov 10, 2026. Filed Nov 12, 2026 (TR-1 holding notification).

Stake
27.80%
Shares
5,350,075
What changed
Fell below 28%

The filing in full

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:4basebio PLC
1b. Please indicate if the issuer is a non-UK issuer(please mark with an “X” if appropriate)
Non-UK issuer
2\. Reason for the notification(please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsX
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rightsX
Other (please specify) iii:
3\. Details of person subject to the notification obligationiv
NameElevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))
City and country of registered office (if applicable)Wilmington, Delaware, United States
4\. Full name of shareholder(s) (if different from 3.) v
NameFort Aggregator, LP (as direct shareholder) and the Prudential Assurance Company Limited (as the other party to the agreement under DTR5.2.1(a))
City and country of registered office (if applicable)1. Fort Aggregator, LP: Wilmington, Delaware, United States2. Prudential Assurance Company Limited: London, United Kingdom
5\. Date on which the threshold was crossed or reachedvi:10 November 2026
6\. Date on which issuer notified (DD/MM/YYYY):11 November 2026
7\. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached27.8%027.8%5,350,075
Position of previous notification (if applicable)29.9%029.9%4,627,741
8\. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type ofsharesISIN code (if possible)Number of voting rightsix% of voting rights
Direct(DTR5.1)Indirect(DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)
Ordinary shares of €1.00 each under DTR 5.2.1(e)ISIN: GB00BMCLYF7902,923,171015.2%
Ordinary shares of €1.00 each under DTR 5.2.1(a)ISIN: GB00BMCLYF7902,426,904012.6%
SUBTOTAL 8. A5,350,07527.8%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrumentExpirationdatexExercise/Conversion PeriodxiNumber of voting rights that may be acquired if the instrument isexercised/converted.% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrumentExpirationdatexExercise/Conversion PeriodxiPhysical or cashSettlementxiiNumber of voting rights% of voting rights
SUBTOTAL 8.B.2
9\. Information in relation to the person subject to the notification obligation(please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xivX
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Chain 1 in respect of Fort Aggregator, LP:
Elevage Medical Technologies Holdings, LLC15.2%15.2%
Elevage Medical Technologies GP, LLC15.2%15.2%
Fort Aggregator, LP15.2%15.2%
Chain 2 in respect of the Prudential Assurance Company Limited
M&G plc12.6%12.6%
M&G Group Regulated Entity Holding Company Limited12.6%12.6%
M&G Group Limited12.6%12.6%
M&G FA Limited12.6%12.6%
M&G Investment Management Limited12.6%12.6%
10\.In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11\. Additional informationxvi
Fort Aggregator, LP and the Prudential Assurance Company Limited are acting in concert pursuant to DTR 5.2.1(a). As such, the disclosure in sections 7, 8 and 9 of this form reflects their aggregated position. A separate notification will be made on behalf of M&G plc in respect of the Prudential Assurance Company Limited’s shareholding.
Place of completionWilmington, Delaware, United States
Date of completion11 November 2026
  • * *
  • * *
HolderStakeShares
Elevage Medical Technologies Holdings, LLC (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))27.80%5,350,075

Source

Download original · View original at FCA

Related